Ipsen names VP, neurology
This article was originally published in Scrip
New Jersey-based Ipsen Biopharmaceuticals, a specialty-driven company developing treatments for debilitating diseases, has named Donald Pearl vice-president of neurology. Mr Pearl will work closely with senior leadership to build out the neurology commercial structure in the US. He joins Ipsen from SkinMedica, an Allergan Company, where he was recently vice-president of international sales and marketing.